OpGen, Inc

OpGen, Inc

OpGen, Inc

OpGen’s Clinical Services Laboratory uses advanced molecular technologies to analyze pathogens responsible for hospital acquired infections
Founded
2002
Raised
$73.2M
Follow us
Alexa global traffic share
Twitter followers
27 May 2016
$7,230,000
Post-IPO equity

SEC FORM D

sec
23 Feb 2015
$1,243,999
Debt financing
17 Jul 2014
$1,079,917
Debt financing
07 Mar 2012
$17,000,000
Venture capital (Series C)
28 Sep 2010
$17,000,000
Venture capital (Series B)
12 Sep 2007
$23,600,000
Venture capital (Series A)